Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $103.70 USD
Change Today -1.51 / -1.44%
Volume 9.7M
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joel R. Huff Ph.D.

Chairperson of Scientific Advisory Board, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 44 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Joel R. Huff, Ph.D. served as Vice President of Medicinal Chemistry at Merck Research Laboratories until 2004, following 30 years of service. Dr. Huff serves as a Member of the Scientific Advisory Board of Epizyme, Inc. At Merck he led efforts to develop therapeutic agents for HIV, resulting in the discovery of indianvir (Crixivan®), and efavirenz (Stocrin®, Sustiva®). Dr. Huff serves as the Chairperson of Scientific Advisory Board at Gilead Sciences Inc. Dr. Huff ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Massachusetts Institute of Technology
BS
The University of Texas, Austin

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $103.70 USD -1.51

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.